Author(s):
Worldwide, bloodstream infections (BSIs) have a high morbidity rate of 1 to 4 and an estimated 15% to 30% crude death rate. 1, 5-7 Antimicrobial resistance (AMR) is a severe issue, especially for Enterobacteriaceae that are carbapenem-resistant and produce extended-spectrum beta lactamases (ESBLs), such as Escherichia coli and Klebsiella species1,7 (CRE). Only 2 reports on the epidemiology of BSIs have been published in Japan, but neither one includes information on patient comorbidities, microbiologic tests, or BSI severity.
